Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xuefuzhuyu Capsule (new vs original process) in Stable Angina
CTR20132991Phase 2Completed
- Sponsor
- Tianjin Hongrentang Pharmaceutical
- Start
- Aug 2014
- Countries
- 1
01
Overview
A Phase 2 trial of xuefu zhuyu in coronary arteriosclerosis, angina pectoris, sponsored by Tianjin Hongrentang Pharmaceutical. Started Aug 2014; status: completed.
02
Drugs
xuefu zhuyu
03
Conditions
coronary arteriosclerosisangina pectoris
Beyond the preview
Go deeper on CTR20132991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132991.